Olema Pharmaceuticals, Inc. Common Stock (OLMA) is a publicly traded Healthcare sector company. As of July 28, 2026, OLMA trades at $12.29 with a market cap of $1.02B and a P/E ratio of -6.63. OLMA moved +2.69% today. Year to date, OLMA is -51.96%; over the trailing twelve months it is +154.99%. Its 52-week range spans $2.86 to $36.26. Analyst consensus is strong buy with an average price target of $37.83. Rallies surfaces OLMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for OLMA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $12.29 |
| Market Cap | $1.02B |
| P/E Ratio | -6.63 |
| EPS | $-1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.26 |
| 52-Week Low | $2.86 |
| Volume | 900.99K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-162.45M |
| Gross Margin | 0.00% |
8 analysts cover OLMA: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.83.